Journal of Cachexia Sarcopenia and Muscle

Papers
(The H4-Index of Journal of Cachexia Sarcopenia and Muscle is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Impaired muscle function, including its decline, is related to greater long‐term late‐life dementia risk in older women627
Muscle Mass Index Decline as a Predictor of Lung Function Reduction in the General Population335
Lonafarnib Protects Against Muscle Atrophy Induced by Dexamethasone234
Acute Sarcopenia: Systematic Review and Meta‐Analysis on Its Incidence and Muscle Parameter Shifts During Hospitalisation161
Testosterone Modulation of Muscle Transcriptomic Profile During Lifestyle Therapy in Older Men with Obesity and Hypogonadism143
Enhancing oncological care: A guide to setting up a new multidisciplinary cancer cachexia clinic within a tertiary centre109
Prognostic utility of self‐reported sarcopenia (SARC‐F) in the Multiethnic Cohort106
Protein intake and bone mineral density: Cross‐sectional relationship and longitudinal effects in older adults103
A new computed tomography‐based approach to quantify swallowing muscle volume by measuring tongue muscle area in a single slice99
TRIM16 facilitates SIRT‐1‐dependent regulation of antioxidant response to alleviate age‐related sarcopenia94
Electrical stimulated GLUT4 signalling attenuates critical illness‐associated muscle wasting92
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 202189
Test–retest reliability and follow‐up of muscle magnetic resonance elastography in adults with and without muscle diseases89
Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy88
Application of the D3‐creatine muscle mass assessment tool to a geriatric weight loss trial: A pilot study87
Maternal vitamin D deficiency affects the morphology and function of glycolytic muscle in adult offspring rats83
Body composition reference ranges in community‐dwelling adults using dual‐energy X‐ray absorptiometry: the Australian Body Composition (ABC) Study80
Issue Information77
Molecular mechanisms of post‐burn muscle wasting and the therapeutic potential of physical exercise76
Issue Information75
With Appreciation74
Comment on “Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis” by Prokopidis et al.73
Doubly labelled water‐calibrated energy intake associations with mortality risk among older adults72
Intramuscular tetanus neurotoxin reverses muscle atrophy: a randomized controlled trial in dogs with spinal cord injury70
The combined effect of cardiorespiratory and muscular fitness on the incidence of metabolic syndrome before midlife64
Resistance and endurance exercise training improves muscle mass and the inflammatory/fibrotic transcriptome in a rhabdomyosarcoma model64
Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis64
Issue Information63
Different effects of low muscle mass on the risk of non‐alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort62
Issue Information61
Associations between dynapenia, cardiovascular hospitalizations, and all‐cause mortality among patients on haemodialysis60
Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease57
Tumour catabolism independent of malnutrition and inflammation in upper GI cancer patients revealed by longitudinal metabolomics57
The association between weight change after gastric cancer surgery and type 2 diabetes risk: A nationwide cohort study56
Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?56
56
Apples to apples? Discordant definitions still hinder evidence‐based treatments for sarcopenia55
The relationship between weight gain during chemotherapy and outcomes in patients with advanced non‐small cell lung cancer54
Does COVID‐19‐related cachexia mimic cancer‐related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management53
Short‐term disuse does not affect postabsorptive or postprandial muscle protein fractional breakdown rates53
Cross‐sectional and longitudinal associations between body flexibility and sarcopenia52
A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach52
The p97‐Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis50
Cross‐sectional and longitudinal association between atrial fibrillation and sarcopenia: Findings from the Korean frailty and aging cohort study49
Leisure‐time physical activity and sarcopenia among older adults from low‐ and middle‐income countries49
Abstracts48
Sarcopenia knowledge of geriatric rehabilitation patients is low while they are willing to start sarcopenia treatment: EMPOWER‐GR48
Comment on “Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer” by Xie et al. — The authors reply47
0.19991779327393